Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Vaccine Funding Bills May Raise Profile Of Shortages On Capitol Hill

Executive Summary

A legislative push to expand funding for immunizations could bring increased Congressional interest in vaccine shortages

You may also be interested in...



Vaccine Preservative Injury Claims Would Be Covered By VICP In Frist Bill

Vaccine injury claimants citing product preservatives as the cause of defects would be required to work through the Vaccine Injury Compensation Program under legislation introduced by Sen. Bill Frist (R-Tenn.)

Drug Discontinuation Requirements Would Be Expanded Under DeWine Bill

Manufacturers that intend to discontinue drugs or biologics would have to notify FDA even if the products to be discontinued are multi-source, under a bill introduced by Sen. Mike DeWine (D-Ohio)

Vaccine Preservative Injury Claims Would Be Covered By VICP In Frist Bill

Vaccine injury claimants citing product preservatives as the cause of defects would be required to work through the Vaccine Injury Compensation Program under legislation introduced by Sen. Bill Frist (R-Tenn.)

Related Content

Latest Headlines
See All
UsernamePublicRestriction

Register

PS039560

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel